Cipla | CIPLA - Net Income


Cipla reported INR8.78B in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
Arca Biopharma USD -31.82M 2.24M Mar/2026
aTyr Pharma USD -134K 19K Jun/2026
Bio Path USD -270K 706K Mar/2026
Brainstorm Cell Therapeutics USD -2.13M 21K Mar/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cara Therapeutics USD -6.8M 1.28M Mar/2026
Cipla INR 8.78B 884.9M Sep/2026
Dr.Reddys Laboratories INR 9.25B 4.81B Sep/2026
Immunic USD -19.3M 6.28M Dec/2025
Minerva Neurosciences USD 1.44M 21.07M Dec/2024
Nektar Therapeutics USD -44.9M 8.82M Mar/2026
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
Sun Pharmaceuticals INR 19.89B 9.06B Sep/2026
TherapeuticsMD USD -1.09M 356K Jun/2024
UPL INR 4.21B 4.13B Sep/2026